Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Ambulatory 2
Transcript
Esophageal Cancer ï· Demonstrate knowledge of the epidemiology, incidence rates, and mortality rates ï· Demonstrate knowledge of pathology including squamous cell, adenocarcinoma, and mixed histology ï· Demonstrate knowledge of risk factors including Barrett's esophagus, gastroesophageal reflux disease, smoking and alcohol use, genetic and molecular abnormalities ï· Demonstrate knowledge of diagnosis of esophageal cancer including as clinical signs and symptoms such as dysphagia, early satiety, and weight loss; endoscopy and biopsy, imaging ï· Demonstrate knowledge of TNM staging and treatment of local-regional disease or recurrent and metastatic disease with a multimodality approach ï· Demonstrate knowledge of supportive care including management of obstruction with endoscopic stenting Gallbladder Cancer ï· Demonstrate knowledge of the epidemiology, incidence rates, and mortality rates ï· Demonstrate knowledge of the risk factors including inflammatory bowel disease, cholesterol type gallstones, and chronic inflammation ï· Demonstrate knowledge of clinical signs and symptoms of gallbladder cancer ï· Demonstrate knowledge of imaging, surgery, bile cytology in making a diagnosis ï· Demonstrate knowledge of the TMN staging system for gallbladder cancer ï· Demonstrate knowledge of treatment based on the stage of gallbladder cancer ï· Demonstrate knowledge of treatment of recurrent or metastatic disease with chemotherapy or radiation therapy ï· Demonstrate knowledge of supportive care for gallbladder cancer including use of biliary drainage Gastric Cancer ï· Demonstrate knowledge of the epidemiology, incidence rates, and mortality rates ï· Demonstrate knowledge of the genetic and molecular factors involved in the development of gastric cancer including precursor lesions, adenomatous and gastric polyps ï· Demonstrate knowledge of risk factors such as b12 deficiency/pernicious anemia, tobacco use, occupational exposure, and H pylori infection and its association with gastric cancer ï· Understand the role of screening with endoscopy for patients at risk for gastric cancer ï· Understand the clinical signs and symptoms, imaging, and use of endoscopy with biopsy in diagnosing gastric cancer ï· Demonstrate knowledge of the TMN staging of gastric cancer ï· Demonstrate knowledge regarding treatment of local gastric cancer ï· Demonstrate knowledge regarding treatment of unresectable and metastatic disease Hepatocellular cancer ï· Demonstrate knowledge of the epidemiology, incidence rates, and mortality rates ï· Demonstrate knowledge of the relationship of Hepatitis B, Hepatitis C, and cirrhosis to the development of HCC ï· Demonstrate knowledge of the genetic relationship between hemochromatosis, Wilson's disease, alpha1-antitrypsin deficiency and HCC ï· Understand the environmental factors including exposure to alcohol and alphatoxin and HCC ï· Understand prevention of HCC with hepatitis B vaccines, alcohol and tobacco cessation ï· Demonstrate knowledge of screening of high risk patients with ultrasound and alpha-fetoprotein ï· Demonstrate clinical signs and symptoms of HCC including ascites, jaundice, confusion, pain, weight loss ï· Demonstrate knowledge of imaging techniques used in diagnosis and staging of HCC including ultrasound, MRI, and four phase CT scans of the liver ï· Understand the role of imaging, alpha-fetoprotein level, and biopsy in diagnosing HCC ï· Understand the Barcelona and TMN staging systems of HCC and the impact of cirrhosis on the Barcelona Staging System ï· Demonstrate knowledge of treatment of resectable disease ï· Demonstrate knowledge of treatment options for unresectable liver- only disease ï· Demostrate knowledge of the treatment of multifocal liver cancer and metastatic disease 6
